The pharmaceutical industry’s growth prospects look promising due to the adoption of advanced technologies, growth in research and development (R&D) initiatives, rise in chronic diseases, a rapidly aging population, and the development of drugs for rare conditions.
Therefore, it could be wise to consider buying fundamentally strong pharma stocks: Amphastar Pharmaceuticals, Inc. (AMPH), Bausch Health Companies Inc. (BHC), and ACADIA Pharmaceuticals Inc. (ACAD).
